BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology. 1997;25:63-70. [PMID: 8985266 DOI: 10.1053/jhep.1997.v25.pm0008985266] [Cited by in Crossref: 14] [Cited by in F6Publishing: 34] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Abid S, Ali S, Baig MA, Waheed AA. Is it time to replace propranolol with carvedilol for portal hypertension? World J Gastrointest Endosc 2015; 7(5): 532-539 [PMID: 25992192 DOI: 10.4253/wjge.v7.i5.532] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Piyachaturawat P, Siramolpiwat S, Sonsiri K, Tangkijvanich P, Treeprasertsuk S. Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up. JGH Open 2018;2:172-7. [PMID: 30483585 DOI: 10.1002/jgh3.12063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Boulay F, Berthier F, Dahan MDC, Tran A. Seasonal variations in variceal bleeding mortality and hospitalization in France. Am J Gastroenterol 2001;96:1881-7. [PMID: 11419844 DOI: 10.1111/j.1572-0241.2001.03889.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
4 Bartell N, Al-Judaibi B. The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon. Saudi J Gastroenterol 2018;24:3-4. [PMID: 29451177 DOI: 10.4103/sjg.SJG_588_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sorbi D, Gostout CJ, Peura D, Johnson D, Lanza F, Foutch PG, Schleck CD, Zinsmeister AR. An assessment of the management of acute bleeding varices: a multicenter prospective member-based study. Am J Gastroenterol. 2003;98:2424-2434. [PMID: 14638344 DOI: 10.1111/j.1572-0241.2003.t01-1-07705.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
6 Qi XS, Bai M, Fan DM. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis. World J Gastroenterol 2014; 20(32): 11463-11466 [PMID: 25170238 DOI: 10.3748/wjg.v20.i32.11463] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
7 Orozco H, Mercado MA, Chan C, Guillén-Navarro E, López-Martínez LM. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy, and surgery: a prospective, controlled, and randomized trial during 10 years. Ann. Surg. 2000;232:216-219. [PMID: 10903600 DOI: 10.1097/00000658-200008000-00011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
8 Ishida J, Konishi M, Ebner N, Springer J. Repurposing of approved cardiovascular drugs. J Transl Med 2016;14:269. [PMID: 27646033 DOI: 10.1186/s12967-016-1031-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
9 Rockey DC. Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices. Curr Gastroenterol Rep 2006;8:7-13. [PMID: 16510029 DOI: 10.1007/s11894-006-0058-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Bari K, Garcia-Tsao G. Treatment of portal hypertension. World J Gastroenterol 2012; 18(11): 1166-1175 [PMID: 22468079 DOI: 10.3748/wjg.v18.i11.1166] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 70] [Article Influence: 9.0] [Reference Citation Analysis]
11 Snoga JL, Lusk KA, Attridge RT, Attridge RL. Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis. Ann Pharmacother 2020;54:322-30. [PMID: 31701773 DOI: 10.1177/1060028019886529] [Reference Citation Analysis]
12 Kumar A, Sharma P, Anikhindi SA, Prajapati R, Agarwal R, Sharma B, Bansal N, Singla V, Arora A. Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis. J Clin Exp Hepatol. 2017;7:275-283. [PMID: 29234190 DOI: 10.1016/j.jceh.2017.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
13 Yin L, Liu H, Zhang Y, Rong W. The surgical treatment for portal hypertension: a systematic review and meta-analysis. ISRN Gastroenterol 2013;2013:464053. [PMID: 23509634 DOI: 10.1155/2013/464053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 O’Brien J, Triantos C, Burroughs AK. Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10:402-412. [PMID: 23545523 DOI: 10.1038/nrgastro.2013.51] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
15 Targownik LE, Spiegel BM, Dulai GS, Karsan HA, Gralnek IM. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Am J Gastroenterol. 2004;99:1306-1315. [PMID: 15233670 DOI: 10.1111/j.1572-0241.2004.30754.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
16 Phillips W, Piller LB, Williamson JD, Whittle J, Jafri SZ, Ford CE, Einhorn PT, Oparil S, Furberg CD, Grimm RH Jr, Alderman MH, Davis BR, Probstfield JL; ALLHAT Collaborative Research Group. Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT. J Clin Hypertens (Greenwich) 2013;15:825-32. [PMID: 24283598 DOI: 10.1111/jch.12180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
17 Rubenstein JH, Eisen GM, Inadomi JM. A Cost-Utility Analysis of Secondary Prophylaxis for Variceal Hemorrhage. Am J Gastroenterology 2004;99:1274-88. [DOI: 10.1111/j.1572-0241.2004.04153.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
18 Kim DH, Park JY. Prevention and management of variceal hemorrhage. Int J Hepatol 2013;2013:434609. [PMID: 23606973 DOI: 10.1155/2013/434609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
19 Ding SH, Liu J, Wang JP. Efficacy of β-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: A meta-analysis. World J Gastroenterol 2009; 15(17): 2151-2155 [PMID: 19418589 DOI: 10.3748/wjg.15.2151] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
20 Bhutta AQ, Garcia-Tsao G, Reddy KR, Tandon P, Wong F, O'Leary JG, Acharya C, Banerjee D, Abraldes JG, Jones TM, Shaw J, Deng Y, Ciarleglio M, Bajaj JS. Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation. Aliment Pharmacol Ther 2018;47:78-85. [PMID: 28994122 DOI: 10.1111/apt.14366] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
21 Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: Evidence-based indications and limitations. JHEP Rep 2020;2:100063. [PMID: 32039404 DOI: 10.1016/j.jhepr.2019.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
22 Poynard T, Thabut D, Munteanu M, Ratziu V, Benhamou Y, Deckmyn O. Hirsch index and truth survival in clinical research. PLoS One 2010;5:e12044. [PMID: 20700455 DOI: 10.1371/journal.pone.0012044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
23 Lebrec D. Drug therapy for portal hypertension. Gut 2001;49:441-2. [PMID: 11511569 DOI: 10.1136/gut.49.3.441] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Flemming JA, Saxena V, Shen H, Terrault NA, Rongey C. Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA. Dig Dis Sci. 2016;61:62-69. [PMID: 26363933 DOI: 10.1007/s10620-015-3865-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
25 Kuo SZ, Lizaola B, Hayssen H, Lai JC. Beta-blockers and physical frailty in patients with end-stage liver disease. World J Gastroenterol 2018; 24(33): 3770-3775 [PMID: 30197482 DOI: 10.3748/wjg.v24.i33.3770] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Pomier-Layrargues G, Villeneuve JP, Deschênes M, Bui B, Perreault P, Fenyves D, Willems B, Marleau D, Bilodeau M, Lafortune M, Dufresne MP. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001;48:390-6. [PMID: 11171831 DOI: 10.1136/gut.48.3.390] [Cited by in Crossref: 100] [Cited by in F6Publishing: 76] [Article Influence: 5.0] [Reference Citation Analysis]
27 Koga H, Ide T, Oho K, Kuwahara R, Hino T, Ogata K, Hisamochi A, Tanaka K, Kumashiro R, Toyonaga A. Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis. Hepatol Res. 2007;37:503-509. [PMID: 17539992 DOI: 10.1111/j.1872-034x.2007.00087.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
28 D’amico G, Perricone G. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter? Curr Hepatology Rep 2019;18:144-56. [DOI: 10.1007/s11901-019-00473-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Zhang F, Liu T, Gao P, Fei S. Predictive Value of a Noninvasive Serological Hepatic Fibrosis Scoring System in Cirrhosis Combined with Oesophageal Varices. Can J Gastroenterol Hepatol 2018;2018:7671508. [PMID: 30186822 DOI: 10.1155/2018/7671508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Seo YS, Kim YH, Ahn SH, Yu SK, Baik SK, Choi SK, Heo J, Hahn T, Yoo TW, Cho SH. Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med Sci. 2008;23:635-643. [PMID: 18756050 DOI: 10.3346/jkms.2008.23.4.635] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
31 Coelho FF, Perini MV, Kruger JA, Fonseca GM, Araújo RL, Makdissi FF, Lupinacci RM, Herman P. Management of variceal hemorrhage: current concepts. Arq Bras Cir Dig 2014;27:138-44. [PMID: 25004293 DOI: 10.1590/s0102-67202014000200011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Lin LL, Du SM, Fu Y, Gu HY, Wang L, Jian ZY, Shen XF, Luo J, Zhang C. Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials. Oncotarget 2017;8:57399-408. [PMID: 28915680 DOI: 10.18632/oncotarget.18143] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
33 Sokucu S, Suoglu O, Elkabes B, Saner G. Long-term outcome after sclerotherapy withor without a beta-blocker for variceal bleeding in children. Pediatr Int 2003;45:388-94. [DOI: 10.1046/j.1442-200x.2003.01743.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
34 Shi L, Zhang X, Li J, Bai X. Favorable Effects of Endoscopic Ligation Combined with Drugs on Rebleeding and Mortality in Cirrhotic Patients: A Network Meta-Analysis. Dig Dis 2018;36:136-49. [PMID: 29161702 DOI: 10.1159/000484082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]